Opinion

Video

Patient Perceptions of Cervical Cancer Screening

Author(s):

Claire Friedman, MD,Emily Davan, RN

The expert panel discusses ways doctors can make cervical cancer screening easier in terms of access and the patient experience.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      Image of Dr. Salani.
      Empowering Patients and Advocating For Yourself After Cervical Cancer
      AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns
      AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns
      Image of a man with gray facial hair and a navy blue suit with a light orange tie.
      Second-Line Tivdak ‘Very Beneficial’ in Cervical Cancer
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Myths Around Cervical Cancer
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Cervical Cancer: Insight into the Patient Experience
      Linda Ryan, a patient advocate
      Cervical Cancer: Advocating for Yourself and Communicating With Family
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Shared Decision-Making in Cervical Cancer
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Unmet Needs in the Cervical Cancer Treatment Landscape
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Tisotumab Vedotin for Patients With Cervical Cancer
      A panel of 3 experts on cervical cancer seated on chairs in a studio
      Individualized Treatment Selection in Cervical Cancer
      Related Content
      Biomarker testing is vital for all patients with lung cancer: © stock.adobe.com.
      May 8th 2025

      Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

      Spencer Feldman
      Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations.
      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
      January 22nd 2024

      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

      Alex Biese Brielle Benyon
      We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
      Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks: © stock.adobe.com
      April 18th 2025

      Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks

      Alex Biese
      Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.
      Kate Weissman, a gynecologic cancer survivor
      November 30th 2023

      Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

      Alex Biese
      Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
      Image of doctor consulting a woman.
      February 28th 2025

      Chemoradiation Benefits for Cervical Cancer May Decline After Age 80

      Spencer Feldman
      Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study using SEER data.
      Illustration of female reproductive system.
      September 14th 2024

      Keytruda Plus Chemoradiotherapy May Represent New Standard of Care in Cervical Cancer Subset

      Kristi Rosa
      Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated with Keytruda plus chemoradiotherapy.